EFFECTIVENESS OF FLASH GLUCOSE MONITORING IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES

Session Name
GLUCOSE SENSORS
Session Type
E-POSTER VIEWING (EXHIBITION HOURS)
Date
20.02.2020, Thursday
Session Time
09:30 - 15:30
Channel
E-Poster Area
Lecture Time
09:30 - 09:30
Presenter
  • Carmen Quirós, Spain
Authors
  • Carmen Quirós, Spain
  • Silvia Rodriguez, Spain
  • Dunia Sanchez, Spain
  • Rosangela Tomasini, Spain
  • Maite Valverde, Spain

Abstract

Background and Aims

Outcomes of using flash glucose monitoring (FGM) have been reported in adults and in clinical trials, less information is available in children and adolescents during real-life settings. This study is evaluating the use and outcomes of FGM in children and teenagers with type 1 diabetes.

Methods

FGM had been initiated in children and adolescents (6 to 17 years) from April to June 2019 in real-life settings. Educational program included 2 visits in groups of 4-8 patients at the time of initiation and 1 individualised visit during of first month of sensor wearing.

Results

A total of 31 children and teenagers (54.8% male; age 11.9±3.0 years, type 1 diabetes duration 4.7±3.1 years) had been included from April to June of 2019. Baseline HbA1c was 8.4±1.1. During the first 2 weeks of sensor wearing 75.5±27.9 % of data were collected. TIR was 38.8±15.7%, with 56.5±17.7% of time in hyperglycaemia (>180mg/dL) and 4.9±4.5% of time in hypoglycaemia (<70mg/dL). Patients performed 7.5±1.8 SMBG/day before FGM initiation and scanned 7.5±5.5 times/day during the first 2 weeks of sensor wearing. Diabetes related quality of life had been measured (PedsQL tests for patients and parents) baseline.

The same data will be collected at 6 months and compared with baseline. Moreover, % of therapy discontinuation, the reasons and technical incidences will be collected.

Conclusions

The evaluation of the effectiveness in terms of metabolic control and quality of life of FGM in real-life settings is important in order to corroborate the clinical trials data.

Hide